Search research articles
Contact Us
Filters
Showing results (41-50 of 141) with videos related to
Page
of 15
Sort By:
Breast Cancer Research and Treatment
|
February 15, 2013
Landscape and evolution of therapeutic research for breast cancer patients
Semih Dogan, Maria Vittoria Dieci, Aicha Goubar, et al.
Breast Cancer Research : BCR
|
September 6, 2014
Clinical development of mTOR inhibitors in breast cancer
Cecile Vicier, Maria Vittoria Dieci, Monica Arnedos, et al.
Cancer Discovery
|
April 3, 2021
Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies
Mihaela Aldea, Fabrice Andre, Aurelien Marabelle, et al.
Nature Reviews. Clinical Oncology
|
July 22, 2015
Precision medicine for metastatic breast cancer--limitations and solutions
Monica Arnedos, Cecile Vicier, Sherene Loi, et al.
Lancet (London, England)
|
March 9, 2020
Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
Laura M Spring, Seth A Wander, Fabrice Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2008
Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer
Lajos Pusztai, Kristine Broglio, Fabrice Andre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2012
Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer
Fabrice Andre, Maria V Dieci, Peter Dubsky, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 23, 2017
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies
Giandomenico Roviello, Fabrice Andre, Sergio Venturini, et al.
Bulletin Du Cancer
|
November 12, 2003
[Exosomes and anti-tumour immunotherapy]
Nathalie Chaput, Fabrice Andre, Noël E C Schartz, et al.
Briefings in Bioinformatics
|
January 19, 2025
A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing
Arnaud Guille, José Adélaïde, Pascal Finetti, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 141) with videos related to
Sort By:
Page
of 15
Breast Cancer Research and Treatment
|
February 15, 2013
Landscape and evolution of therapeutic research for breast cancer patients
Semih Dogan, Maria Vittoria Dieci, Aicha Goubar, et al.
Breast Cancer Research : BCR
|
September 6, 2014
Clinical development of mTOR inhibitors in breast cancer
Cecile Vicier, Maria Vittoria Dieci, Monica Arnedos, et al.
Cancer Discovery
|
April 3, 2021
Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies
Mihaela Aldea, Fabrice Andre, Aurelien Marabelle, et al.
Nature Reviews. Clinical Oncology
|
July 22, 2015
Precision medicine for metastatic breast cancer--limitations and solutions
Monica Arnedos, Cecile Vicier, Sherene Loi, et al.
Lancet (London, England)
|
March 9, 2020
Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
Laura M Spring, Seth A Wander, Fabrice Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2008
Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer
Lajos Pusztai, Kristine Broglio, Fabrice Andre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2012
Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer
Fabrice Andre, Maria V Dieci, Peter Dubsky, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 23, 2017
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies
Giandomenico Roviello, Fabrice Andre, Sergio Venturini, et al.
Bulletin Du Cancer
|
November 12, 2003
[Exosomes and anti-tumour immunotherapy]
Nathalie Chaput, Fabrice Andre, Noël E C Schartz, et al.
Briefings in Bioinformatics
|
January 19, 2025
A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing
Arnaud Guille, José Adélaïde, Pascal Finetti, et al.
Page
of 15